| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 3 | 0.0003 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 7 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 7 | 0.0000 |
| 5 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 9 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 10 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 11 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |